0001396677-16-000142.txt : 20161216
0001396677-16-000142.hdr.sgml : 20161216
20161216123531
ACCESSION NUMBER: 0001396677-16-000142
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161214
FILED AS OF DATE: 20161216
DATE AS OF CHANGE: 20161216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP
CENTRAL INDEX KEY: 0001050007
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 870515089
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 1400 KEARNS BOULEVARD
STREET 2: 2ND FLOOR
CITY: PARK CITY
STATE: UT
ZIP: 84060
BUSINESS PHONE: 4356556000
MAIL ADDRESS:
STREET 1: 1400 KEARNS BOULEVARD
STREET 2: 2ND FLOOR
CITY: PARK CITY
STATE: UT
ZIP: 84060
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seelos Andrew W
CENTRAL INDEX KEY: 0001396677
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23731
FILM NUMBER: 162055715
MAIL ADDRESS:
STREET 1: C/O NUTRACEUTICAL CORPORATION
STREET 2: 1400 KEARNS BOULEVARD, 2ND FLOOR
CITY: PARK CITY
STATE: X1
ZIP: 84060
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2016-12-14
0
0001050007
NUTRACEUTICAL INTERNATIONAL CORP
NUTR
0001396677
Seelos Andrew W
C/O NUTRACEUTICAL CORPORATION
1400 KEARNS BOULEVARD, 2ND FLOOR
PARK CITY
X1
84060
UNITED STATES
0
1
0
0
Asst VP & Controller
Common Stock
2016-12-14
4
A
0
1449.28
34.5
A
22514.893
D
The acquisition reported in this Form 4 was a stock award under the Issuer's 2013 Long-Term Equity Incentive Plan approved by the Issuer's Compensation Committee on December 9, 2016 and granted on December 14, 2016. The stock award was fully vested on the date of the grant.
/s/ Alison Pitt, attorney in fact
2016-12-16